Concepedia

Koji Nagaoka

KN

14

Publications

415

Citations

12

H-Index

2014

Active since

Affiliations

University of Tokyo Hospital(Current)

The University of Tokyo

RIKEN Center for Integrative Medical Sciences

Keio University

Juntendo University

Koji Nagaoka is an author at University of Tokyo Hospital specializing in medicine, tumor immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2014–2023

14

Publications

14

Increased diversity with reduced “diversity evenness” of tumor infiltrating T-cells for the successful cancer immunotherapy

Akihiro Hosoi, Kazuyoshi Takeda, Koji Nagaoka et al. · Scientific Reports · 2018 · 68 citations · Full text

Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy

Koji Nagaoka, Masataka Shirai, Kiyomi Taniguchi et al. · Journal for ImmunoTherapy of Cancer · 2020 · 65 citations · Full text

Established gastric cancer cell lines transplantable into C57<scp>BL</scp>/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth

Masami Yamamoto, Sachiyo Nomura, Akihiro Hosoi et al. · Cancer Science · 2018 · 58 citations · Full text

Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study

Kazuhiro Kakimi, Hirokazu Matsushita, Keita Masuzawa et al. · Journal for ImmunoTherapy of Cancer · 2020 · 40 citations · Full text

Dendritic cell vaccine induces antigen-specific CD8<sup>+</sup> T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade

Koji Nagaoka, Akihiro Hosoi, Tamaki Iino et al. · OncoImmunology · 2017 · 31 citations · Full text

, , +21

Rows per page

1–5 of 14